Apex Diagnostic Labs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-07-2024
- Paid Up Capital ₹ 0.10 M
as on 04-07-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Revenue %
(FY 2021)
- Profit -407.53%
(FY 2021)
- Ebitda -157.39%
(FY 2021)
- Net Worth -99.38%
(FY 2021)
- Total Assets -39.72%
(FY 2021)
About Apex Diagnostic Labs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saransh Goyal, Seema Kanwar, Shobha Kanwar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999RJ2018PTC059907
- Company No.
059907
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Apex Diagnostic Labs?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saransh Goyal  | Director | 26-Jul-2018 | Current |
| Seema Kanwar | Director | 01-Jan-2018 | Current |
| Shobha Kanwar | Director | 01-Jan-2018 | Current |
| Dharmendra Singh | Director | 01-Jan-2018 | Current |
| Narendra Tanwar | Director | 01-Jan-2018 | Current |
Financial Performance of Apex Diagnostic Labs.
Apex Diagnostic Labs Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 407.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 99.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apex Diagnostic Labs?
Unlock access to Apex Diagnostic Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Snd Infraprojects Private LimitedActive 4 years 9 monthsDharmendra Singh and Narendra Tanwar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Apex Diagnostic Labs?
Apex Diagnostic Labs has a workforce of 9 employees as of May 14, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Diagnostic Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Diagnostic Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
